Saturday 17 October 2026 Export NGVT’s income statement to Excel — free account

Ingevity Corporation

NGVT Basic Materials Specialty Chemicals

In the quarter to June 2026, revenue fell 5.25%, EPS grew 125.4%, free cash flow fell 136.1% and total debt fell 14.5%, each against the same quarter a year earlier.

69.82 0.72 −1.02%

Follow NGVT

Alert me

Market cap: $2.4B
P/E: 45.3×
Fwd P/E: 18.5×
Dividend yield: —
F-score: 6/9
Altman Z: 1.84
Beneish M: −4.00
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 1.76

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	1	—	—	3	—	—

Insider Ownership 2.22%

Capital & Financial Ratios $m

Market Cap 2,430.00

Revenue 1,160.30

Net Income 54.00

Free Cash Flow 154.90

Net Debt 873.00

Current Ratio 1.61

Debt/Equity 22.52

P/E ratio 45.34

Fwd P/E 18.50

P/S ratio 2.09

P/B ratio 51.64

Past 5Y EPS Growth —

This Y EPS Growth 17.66%

Next Y EPS Growth 12.76%

Next Y revenue growth (4.93%)

Next 5Y EPS Growth 14.28%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 85.29%

10-year low 10-year high

P/S against its own 10 years 52.43%

10-year low 10-year high

P/B against its own 10 years 93.23%

10-year low 10-year high

EV/Sales against its own 10 years 45.25%

10-year low 10-year high

EV/FCF against its own 10 years 33.04%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	96	68	78	183
Receivables	182	132	127	156
Inventory	309	196	186	154
Other	—	—	—	—
	659	493	454	544

	2023	2024	2025	Q'26
Payables	158	95	92	88
ST’ Debt	—	—	—	—
Other	—	—	—	—
	363	264	341	338

Compound Annual Growth %

	10y	5y	3y
Sales	2.00%	(0.81%)	(11.21%)
Cash Flow	16.45%	(1.23%)	1.86%
Earnings	0.00%	0.00%	0.00%
Book Value	(24.86%)	(45.92%)	(65.09%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	258	314	—	—	—
’25	248	332	333	255	1,168
’24	340	391	334	136	1,200
’23	393	482	446	—	1,216
’22	383	420	482	384	1,668
’21	320	358	377	336	1,392
’20	288	271	332	326	1,216

Fiscal quarters ending in the months shown.

value withheld pending a data check

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(2)	(14)	—	—	—
’25	25	79	130	97	331
’24	(12)	30	47	65	129
’23	5	48	105	46	205
’22	24	91	100	99	313
’21	51	66	100	76	293
’20	60	49	90	153	352

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(12)	(24)	—	—	—
’25	19	67	114	77	277
’24	(29)	12	29	40	51
’23	(20)	27	72	17	95
’22	(3)	61	64	49	171
’21	34	42	75	39	190
’20	41	34	74	122	270

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	1.66	1.00	—	—	—
’25	0.56	(4.02)	1.18	(2.37)	(4.61)
’24	(1.54)	(7.81)	(2.95)	0.46	(11.85)
’23	1.35	0.97	0.69	(3.23)	(0.15)
’22	1.55	1.54	1.98	0.41	5.50
’21	1.20	1.10	(0.11)	0.74	2.95
’20	1.08	0.49	1.69	1.23	4.48

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	23.00	51.01	66.57	72.59	24.92	63.43	56.31	36.66	30.90	28.49	Analyst estimates 2026–2028 Powerpack
	High	55.43	80.18	106.59	120.41	88.02	89.55	79.79	90.81	56.30	61.77
People
People	Employees	1,500	1,500	1,750	1,850	1,750	1,850	2,050	1,700	1,600	1,500
	Revenue/emp, $m	0.61	0.65	0.65	0.70	0.69	0.75	0.81	0.72	0.75	0.78
Income, $m
Income, $m	Revenue	908	972	1,134	1,293	1,216	1,392	1,668	1,216	1,200	1,168
	Gross margin, %	30.21	33.83	36.77	37.28	38.28	36.85	34.17	36.61	38.73	39.53
	EBT	87	175	222	228	235	163	270	130	(140)	(142)
	EBT margin, %	9.58	17.98	19.57	17.63	19.33	11.70	16.16	10.70	(11.71)	(12.17)
	Net income	44	145	182	184	181	118	212	(5)	(430)	(167)
	Depreciation	39	40	57	85	100	110	109	123	457	290
Per share, $
Per share, $	Revenue	21.57	23.08	26.97	30.93	29.42	34.95	43.70	33.31	33.04	32.23
	Earnings	0.83	3.00	4.03	4.39	4.51	2.97	5.54	(0.15)	(11.85)	(4.61)
	Cash flow	3.04	4.14	5.99	6.60	8.53	7.37	8.21	5.62	3.54	9.14
	Capex	(1.35)	(1.25)	(2.23)	(2.75)	(1.99)	(2.61)	(3.73)	(3.01)	(2.14)	(1.49)
	Free cash flow	1.69	2.89	3.76	3.85	6.54	4.76	4.48	2.61	1.40	7.65
	Book value	3.20	6.60	8.06	12.70	15.54	16.92	18.29	17.30	5.37	0.82
	Shares, m	42	42	42	42	41	40	38	36	36	36
Valuation, ×
Valuation, ×	P/E	66.48	23.72	20.77	19.95	16.79	24.31	12.87	0.00	0.00	0.00
	P/S	2.47	3.07	3.10	2.83	2.57	2.05	1.63	1.41	1.23	1.84
	P/B	16.64	10.75	10.39	6.88	4.87	4.24	3.88	2.72	7.58	72.18
	EV/Sales	2.97	3.45	3.71	3.75	3.42	2.77	2.47	2.48	2.31	2.78
	EV/FCF	37.89	27.55	26.57	30.10	15.38	20.31	24.14	31.69	54.33	11.71
Cash, $m
Cash, $m	Operating cash flow	128	174	252	276	352	293	313	205	129	331
	Capex	(57)	(53)	(94)	(115)	(82)	(104)	(142)	(110)	(78)	(54)
	Free cash flow	71	122	158	161	270	190	171	95	51	277
Balance, $m
Balance, $m	Working capital	158	216	239	248	405	456	380	296	229	113
	Total debt	489	453	741	1,228	1,267	1,250	1,473	1,383	1,340	1,161
	Net debt	458	366	664	1,172	1,010	975	1,396	1,287	1,272	1,083
	Shareholders’ equity	135	278	339	531	642	674	698	631	195	30
Returns, %
Returns, %	ROA	4.37	14.36	15.07	10.63	8.11	0.00	8.13	(0.20)	(18.52)	(9.10)
	ROIC	10.72	18.56	15.75	9.93	10.34	11.01	9.62	6.54	(1.81)	(2.47)
	ROE	10.80	61.33	54.85	42.25	30.93	0.00	30.84	(0.81)	(104.11)	(148.60)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
ASH Ashland Inc.	$3.3B	62.4×	24.9×	+7.34% (above 0%: growing)	n/m	+5.26% (above 0%: growing)	34.21%	8.65%	Compare
FUL H. B. Fuller Company	$2.8B	14.1×	16.8×	+5.17% (above 0%: growing)	+18.19% (above 0%: growing)	−58.41% (below 0%: shrinking)	33.22%	12.07%	Compare
HWKN Hawkins, Inc.	$2.8B	33.8×	36.3×	+7.64% (above 0%: growing)	−3.55% (below 0%: shrinking)	+30.29% (above 0%: growing)	23.44%	12.25%	Compare
KWR Quaker Houghton	$2.7B	27.9×	25.2×	+10.17% (above 0%: growing)	n/m	−43.19% (below 0%: shrinking)	35.53%	7.62%	Compare
WDFC WD-40 Company	$2.7B	30.3×	34.0×	+24.35% (above 0%: growing)	+45.45% (above 0%: growing)	−13.28% (below 0%: shrinking)	56.59%	20.67%	Compare
NGVT Ingevity Corporation	$2.4B	45.3×	18.5×	−5.25% (below 0%: shrinking)	n/m	−136.08% (below 0%: shrinking)	44.25%	19.13%
IOSP Innospec Inc.	$2.4B	19.7×	16.3×	+11.76% (above 0%: growing)	+32.98% (above 0%: growing)	−63.16% (below 0%: shrinking)	28.14%	8.08%	Compare
MTX Minerals Technologies Inc.	$2.0B	— (loss-making)	12.4×	+3.69% (above 0%: growing)	n/m	+5.92% (above 0%: growing)	24.40%	(40.17%)	Compare
CC The Chemours Company	$1.9B	— (loss-making)	16.9×	−1.49% (below 0%: shrinking)	n/m	+128.00% (above 0%: growing)	17.98%	(13.39%)	Compare
Median of peers	$2.7B	29.1×	20.9×	+7.49%	+25.59%	−4.01%	30.68%	8.37%

All 60 Specialty Chemicals stocks →

Ingevity Corporation (NGVT) key facts

Ingevity Corporation (NGVT) is a Specialty Chemicals company in the Basic Materials sector, listed on the New York Stock Exchange.
As of October 16, 2026, NGVT traded at $69.82, a market capitalization of $2.4 billion.
Return on equity was −148.6% and debt-to-equity 22.52.
Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 1.84 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.